PPD Awarded U.S. Army and BARDA Research

October 8, 2015

Applied Clinical Trials

PPD announced it has been awarded two separate United States government contracts. In one agreement, the U.S. Army selected PPD to provide health outcomes research for armed services personnel. For the Biomedical Advanced Research and Development Authority (BARDA), PPD will evaluate the potency and long-term stability of H5N1 influenza (avian influenza) vaccines from the Centers for Disease Control and Prevention’s Strategic National Stockpile.

Read the full release.